Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
5.49
-0.14 (-2.49%)
At close: Oct 1, 2026, 4:00 PM EDT
5.50
+0.01 (0.18%)
After-hours: Oct 1, 2026, 7:30 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $34.28 million as of October 1, 2026. Its market cap has decreased by -43.13% in one year.
Market Cap
34.28M
Enterprise Value
7.41M
1-Year Change
-43.13%
Ranking
Category
Stock Price
$5.49
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $34.28M, a decrease of -93.80%. That is a compound annual growth rate of -37.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 34.28M | -40.22% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 41.30M |
| Celularity | 39.51M |
| Actinium Pharmaceuticals | 36.16M |
| BriaCell Therapeutics | 35.19M |
| Immutep | 35.16M |
| Seres Therapeutics | 34.30M |
| LeonaBio | 32.69M |
| Quince Therapeutics | 31.20M |